RBC Life Valuation
| RBF619 Fund | 75.84 0.83 1.11% |
RBC Life Science owns a latest Real Value of USD81.42 per share. The recent price of the fund is USD75.84. Our model determines the value of RBC Life Science from evaluating the entity technical indicators and probability of bankruptcy. In general, investors support taking in undervalued funds and trading overvalued funds since, in the future, fund prices and their ongoing real values will converge.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates RBC Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in RBC Life and how it compares across the competition.
About RBC Life Valuation
The fund valuation mechanism determines RBC Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of RBC Life. We calculate exposure to RBC Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of RBC Life's related companies.Other Information on Investing in RBC Fund
RBC Life financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Life security.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |